Asiatic aims to be a pioneer in emerging as one of India's first Hybrid CRO, that integrates technology, and nurtures captive sites from Tier III Cities, to bring a larger pool of Investigators and Patients into the Clinical Research world, for quality completion of clinical studies which would enable quicker new drug development.

Mission

Asiatic company evolved a stringent Quality Policy through a consensus approach by involving various medical professional on the company's panel of advisors and all stakeholders related to clinical studies.

We, at Asiatic Clinical Research Pvt Ltd, are committed to provide Quality services, keeping patient safety as the top most priority, and ensure quality data that meets the exceptions of the Sponsors. We strive to achieve these through a process oriented approach and continual improvement.